Technical leadership, predictive analytics, and personalized medicine can improve patient care. Here's what leaders in ...

The industry is on a strong growth trajectory, with experts predicting notable achievements over the next decade. Forecasts ...

Scientists have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

Cell and gene therapy tout promising results, but manufacturing challenges around personalized treatments require industry ...

We are on the cusp of reimagining healthcare, with AI, wearables, multimodal data, AR/VR, and other innovations rapidly ...

Researchers at Vilnius University have developed an effective approach to liquid biopsy that contributes to the field of ...

AI is not only improving efficiency but also driving equitable and personalized healthcare solutions worldwide. As the industry continues to evolve, AI’s role in healthcare will expand further ...

As we step into 2025, personal health remains a top priority. With advancements in healthcare and wellness technology, taking ...

Scientists have developed an innovative method for growing brain tumors of individual patients in the laboratory that mimic the original structure and the molecular property of the parental tumor as ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

A comprehensive review has explored the diverse roles of extracellular vesicles (EVs) in the oral and maxillofacial region, ...

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.